Hepatitis C virus variant that allows infection in mice expands research opportunities
The only natural host of the hepatitis C virus (HCV) is humans. Model organisms for laboratory studies, especially mice, ...
Medscape13d
HCV Cure Rate Quadruples With Peer-Assisted Telehealth
Having peers facilitate virtual visits may lead to many more patients with hepatitis C receiving treatment and clearing the ...
Healthline25d
The Opioid Epidemic and Hepatitis C Infections: What’s the Connection?
Hepatitis C is a liver disorder caused by the hepatitis C virus (HCV). Hepatitis C can go undetected for years or even decades. It may silently damage your liver, leading to serious health effects.
Daily4d
Hepatocellular Carcinoma After Hepatitis C Cure: Study Emphasizes The Need for Long-Term Surveillance
China: A recent study published in the Annals of Hepatology has emphasized the influence of age on hepatocellular carcinoma ...
Healio10d
Viral hepatitis elimination requires equitable public health approach
Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...
phillyvoice.com5d
Philly's cure rate for hepatitis C has risen to nearly 60% over the last decade
The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.
Science Daily9d
New study identifies key protein's role in psoriasis
In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system. Understanding how 'c-Rel' ...
clinicaladvisor.com11d
Brelovitug Granted Breakthrough Designation for Chronic Hepatitis Delta
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).